Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population | AVESİS

Middle East Technical University Research Information System

Sequential treatment of HCC cells with PI3K/Akt/mTOR pathway inhibitors prior to sorafenib attenuates cancer stem cell population

Copy For Citation

Kahraman D. C. , Kahraman T., ATALAY R.

EUROPEAN JOURNAL OF CANCER, vol.61, 2016 (Journal Indexed in SCI)

Publication Type: Article / Abstract
Volume: 61
Publication Date: 2016
Title of Journal : EUROPEAN JOURNAL OF CANCER